U.S. market Closed. Opens in 3 hours 5 minutes

LRMR | Larimar Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue311.00K272.00K326.00K155.00K78.00KN/AN/AN/AN/A
Gross Profit-311.00K-272.00K-326.00K-155.00K-78.00KN/AN/AN/AN/A
Operating Expenses41.76M36.53M50.47M42.80M23.21M61.12M53.00M58.23M73.81M
Selling, General & Admin14.09M12.28M12.07M11.40M2.42M13.19M12.16M18.29M19.20M
Research & Development27.67M24.25M38.40M31.41M20.79M47.93M40.84M39.94M54.62M
Other Operating ExpensesN/A1.17M-171.00K322.00K82.00KN/AN/AN/AN/A
Operating Income-41.76M-36.53M-50.47M-42.80M-23.21M-61.12M-53.00M-58.23M-73.81M
Other Expenses / Income4.81M1.17M-171.00K322.00K82.00K-246.00K971.00K347.00K-473.00K
Before Tax Income-36.95M-35.35M-50.64M-42.48M-23.13M-61.37M-52.03M-57.88M-74.29M
Income Tax ExpensesN/A-1.17M-326.00K-155.00K-93.86K-492.00KN/AN/AN/A
Net Income-36.95M-34.18M-50.31M-42.33M-23.13M-61.37M-52.03M-57.88M-74.29M
Interest ExpensesN/A-318.00KN/AN/A-1.77M-246.00K971.00K347.00K-473.00K
Basic Shares Outstanding43.90M25.76M17.16M11.88M3.11M2.69M2.29M2.27M2.23M
Diluted Shares Outstanding43.90M25.76M17.16M11.88M3.11M2.69M2.29M2.27M2.23M
EBITDA-41.45M-36.53M-50.47M-42.80M-23.14M-61.35M-50.87M-58.01M-73.74M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-36.95M-35.67M-50.64M-42.48M-24.99M-62.11M-51.06M-57.53M-74.76M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙